被多个强壮的黑人灌满精_天天干夜夜爽_成人特黄午夜性a一级毛片_Av黄色网址在线 - 久久久久久久综合狠狠综合


Redhill Capital manages four RMB funds and one USD fund, with active investments
in more than 50 innovative medical growth companies.

Portfolio

  • 靈犀云
  • 靈犀云

  • 道博醫(yī)療
  • 道博醫(yī)療

  • 樂(lè)橙云服
  • 樂(lè)橙云服

  • HAMESH
  • HAMESH

  • 睿渠
  • 睿渠

  • 信華生物
  • 信華生物

  • 英偉醫(yī)療
  • 英偉醫(yī)療

  • 善思微
  • 善思微

  • 譜洛美施
  • 譜洛美施

  • 深圳市賽諾思醫(yī)療科技有
  • 深圳市賽諾思醫(yī)療科技有限公司成立于2017年3月,由丹麓資本獨(dú)家投資。公司位于深圳市坪山區(qū)國(guó)家級(jí)生物醫(yī)藥產(chǎn)業(yè)基地。公司的創(chuàng)始團(tuán)隊(duì)和技術(shù)顧問(wèn)包含了國(guó)內(nèi)外頂級(jí)心臟電生理專家,心臟外科專家,具有美國(guó)藥監(jiān)局和中國(guó)藥監(jiān)局醫(yī)療器械臨床和注冊(cè)經(jīng)驗(yàn)的專家,以及心血管領(lǐng)域醫(yī)療器械資深研發(fā)人員,是一家專注于心臟電生理領(lǐng)域的新技術(shù)和產(chǎn)品研發(fā)的創(chuàng)新型科技公司。公司研發(fā)的經(jīng)心外膜化學(xué)消融治療房顫裝置,可以顯著降低目前手術(shù)成本,并降低手術(shù)操作要求,提高持續(xù)性房顫消融的手術(shù)成功率,讓更多的房顫病人得到更有效的治療。該技術(shù)為全球首創(chuàng)技術(shù)

  • 深圳韋拓生物科技有限公
  • 深圳韋拓生物科技有限公司(VitaVitro)是一家專注于人類輔助生殖領(lǐng)域的國(guó)家高新技術(shù)企業(yè)。公司成立于2015年,總部位于深圳,合作伙伴遍及全球,主營(yíng)業(yè)務(wù)包括輔助生殖實(shí)驗(yàn)室用全套無(wú)菌試劑,管材及設(shè)備。產(chǎn)品獲得美國(guó)FDA及CFDA認(rèn)證,通過(guò)了歐盟權(quán)威機(jī)構(gòu)ISO13485質(zhì)量體系認(rèn)證,遠(yuǎn)銷歐洲,美洲及亞太地區(qū)并享有良好聲譽(yù)。

  • 香港美亞特醫(yī)
  • 香港美亞特醫(yī)

  • 廣州源博醫(yī)藥科技有限公
  • 源博醫(yī)藥科技一家人用和獸用生物制品研發(fā)企業(yè),基于桿狀病毒、昆蟲細(xì)胞表達(dá)抗原技術(shù)平臺(tái)和結(jié)構(gòu)免疫輔助疫苗設(shè)計(jì)技術(shù)平臺(tái),研發(fā)涉及人用和獸用疫苗及獸用診斷制品等。

  • 廣州源古紀(jì)科技有限公司
  • 源古紀(jì)成立于2019年,公司以呼吸感染賽道為核心,依托國(guó)家呼吸醫(yī)學(xué)中心(廣州呼吸健康研究院等)推進(jìn)網(wǎng)絡(luò)建設(shè),打造以分子檢測(cè)為主(包括但不限于mNGS、二代、 三代測(cè)序),包含檢測(cè)、產(chǎn)品

  • 蘇州新芽基因生物技術(shù)有
  • 新芽基因是一家利用堿基編輯技術(shù)開發(fā)基因治療藥物的公司,該技術(shù)在DMD治療領(lǐng)域顯示出明顯的優(yōu)勢(shì)。新芽基因擁有自主知識(shí)產(chǎn)權(quán)的基因編輯技術(shù)(Targeted AID-mediated Mutagenesis

  • Fujian pilot Free Trad
  • Manteia is committed to deep learning, data technology and traditional algorithm research in the field of tumor radiotherapy. Headquartered in Xiamen, China, with a wholly-owned subsidiary in the United States, it is an enterprise of "double hundred talents" introduced by Xiamen municipal government and a strategic investment enterprise of Fosun Group and Danlu capital in the field of radiotherapy.

    The company has R & D teams in China and American design, with about 50 algorithms and engineers, including 40% doctors and 30% masters. The core R & D personnel have published more than 170 SCI literatures in the field of radiotherapy. It has 26 software copyrights, 2 international patents and 6 domestic patents.
    The company's main research fields are: medical imaging, biological dose, calculation and optimization engine and automatic control. It has completed many software products such as software system "automatic drawing and image workstation", "plan automatic evaluation and optimization system", "safety and information system" and "adaptive radiotherapy system", and has been successfully deployed and applied in hundreds of hospitals at home and abroad.

  • Chongqing mingyitang h
  • 1. Background of medical health group

    Wenkang group has been deeply engaged in the internet medical service and medical big health industry for many years. Its business covers online medical treatment, regional intelligent medical treatment, intelligent health management, pharmaceutical e-commerce, etc. the group has successively obtained heavyweight capital investments such as Yunfeng fund, CCB international and Lenovo holding group.

    2. A modern comprehensive secondary hospital with traditional Chinese medicine characteristics, with stable team and mature operation.

    Founded in October 2016, mingyitang hospital integrates medical diagnosis and treatment, health management, remote consultation and rehabilitation physiotherapy. It has more than 180 traditional Chinese medicine experts. In less than three years of establishment, the number of outpatients has increased by nearly 50% annually, and the average revenue growth rate in recent two years has exceeded 123%.
    3. The regional chain has expanded steadily to build a chain brand of traditional Chinese medicine industry in Sichuan and Chongqing.
    By the end of August 2019, the preliminary chain will be completed, covering 5 outpatient clinics with one hospital in Sichuan and Chongqing. In the next three years, about 30 chain stores will be built through self construction or M & A, so as to become a leading brand in the traditional Chinese medicine industry in Sichuan and Chongqing.

  • Shenzhen haisi'an Biot
  • Founded in 2016, hisan is committed to the in vitro diagnosis (IVD) industry's real-time detection (POCT) segment. It has a unique patented real-time detection technology, focusing on the diagnosis of autoimmune diseases and early detection of infectious

  • Heyuan Biotechnology (
  • Heyuan Biotechnology (Tianjin) Co., Ltd. is a biopharmaceutical enterprise focusing on the R & D of innovative immune cell therapy drugs. It is committed to building the whole industry chain business of R & D, production and sales of immune cell therapy drugs. Founded in June 2018, the company is headquartered in China Trade Center, Chaoyang District, Beijing, and has established an immune cell therapy drug transformation and production base in Tianjin Binhai high tech Zone. Relying on the preliminary technical achievements of domestic first-class hematology hospitals and hematology research institutes, the company speeds up the transformation of scientific research achievements of car-t and other cell therapy drugs.

    At present, the company's first new drug clinical trial application for immune cell therapy product cnct19 has been officially accepted by the State Drug Administration. The follow-up pipeline products will be continuously promoted to provide effective treatment methods for malignant blood tumors such as leukemia and lymphoma. At present, the company has 1300 square meters of R & D center in Beijing, 1400 square meters of GMP immune cell drug R & D, transformation and production facilities in Tianjin, and 7000 square meters of GMP immune cell drug production base is under construction.
    With an efficient R & D and transformation platform, the company will create safe, effective and accessible high-quality cell therapy products for Chinese patients through strict cell therapy product production and quality system!

  • Changzhou Zhishan Medi
  • Zhishan medical was founded in May 2017, initiated by Shanlan capital, Junlian capital and Softbank China capital, and jointly founded by top medical experts and senior medical device industry people in the United States, France and China. Danlu capital led the investment in pre-A. Zhishan medical is engaged in the R & D, production and sales of non-invasive weight loss medical devices. With the mission of "keeping the majority of obese people away from chronic diseases and improving the quality of life", Zhishan medical is committed to becoming a provider of high-quality and cost-effective non-invasive weight loss devices and a promoter of global non-invasive weight loss technology innovation.
    The company has established a large-scale production base in Changzhou, a R & D center in Shanghai Zhangjiang Science City, and liaison offices in the United States and France to select new technologies and promote global business and clinical cooperation. The first product developed by the company, intragastric balloon system, is the first in China and the leading technology in the world.

  • Hunan Kefu Medical Tec
  • Hunan Kefu Medical Technology Development Co., Ltd. (hereinafter referred to as the company), founded in 2009, has 16 subsidiaries and 61 branches. Now it has developed into a group enterprise integrating medical device R & D, manufacturing, sales and service.
    The company is committed to improving the quality of life of the people with more scientific, humanized and intelligent household medical products, and caring for more families with high-quality products. "Cofoe" trademark has been registered in the EU and has submitted registration applications to more than 50 countries around the world. At present, it mainly develops and produces more than 600 categories of products, such as 6864 medical consumables and dressings and 6826 physical therapy and rehabilitation equipment. After years of accumulation, the company has the ability of R & D, production, sales and service of intelligent medical products, and has more than 110 medical device licenses and 216 patents. At present, the company has more than 12000 kinds of products, complete varieties and wide coverage, covering medical devices for pregnant women, household medical devices for newborn children and medical devices for family elderly care, including six product categories: wheelchair, blood glucose meter, sphygmomanometer, oxygen generator, hearing aid and crutch walker, which has reached the industry leading market share of rehabilitation products.

    The company provides diversified products and services for 100000 pharmacies and more than 10 million families in China. Now it is one of the most comprehensive operators in China. Its products are exported to more than 20 countries and regions overseas, and there are storage centers in the United States, Britain, Australia and Russia. The company has set up two R & D centers in Hangzhou and Changsha, two factories in Changsha and Yueyang, Hunan Province, standardized experimental centers and first-class production equipment, and the implementation of ISO9001:2000 and ISO13485 quality systems, which provide a reliable guarantee for product R & D and production quality. The establishment of technology center and sales center has continuously improved the scientific research level and sales capacity, and provided a guarantee for the company to maintain its leading position in the industry.
    In the future, the company will further increase scientific research investment, produce more scientific, innovative, humanized and intelligent adaptive household medical device products, serve tens of millions of families through perfect online and offline channels, and is committed to building "Kefu" into a world-class household medical device brand trusted by consumers.

  • Shenzhen beirelaxed Te
  • Founded in 2000, beirelaxed is an enterprise integrating R & D, production and sales of intelligent portable massagers. Over the years, beieasily has focused on innovative R & D and created a series of portable hand imitation massage products such as head

  • Suzhou liangyihui Netw
  • Liangyihui is an authoritative anti-cancer academic platform, an officially designated cooperation platform of the Chinese society of Clinical Oncology, and a strategic partner of the China Women's foundation. It also maintains long-term and effective in-depth cooperation with many well-known hospitals and authoritative institutions at home and abroad. Liangyihui is committed to solving the situation of information asymmetry in the professional field. It is an efficient tool for oncologists. It will also become a popular science publicity for cancer patients and the public, and an all-round platform for cancer prevention and anti-cancer.

  • Beijing Zhiyuan huitu
  • Beijing Zhiyuan huitu Technology Co., Ltd. (Vistel) is committed to entering the global eye health market of US $200 billion a year through ophthalmic AI and ophthalmic intelligent devices. Vistel was founded by executives and scientists from former Intel, Bell Labs and other companies, and has a number of experts in the field of ophthalmology as medical consultants. Vistel's eyewisdom ? Eye AI solution can analyze and diagnose common blinding eye diseases efficiently, accurately and in real time. Vistel's ophthalmic intelligent hardware equipment is committed to creating innovative devices with high cost performance. Vistel's system is widely used in Ophthalmology, endocrinology and physical examination / optometry centers. In terms of R & D, Vistel has carried out a number of innovative research with Beijing Union Medical College Hospital, Beijing Tongren Hospital, the Third Hospital of Beijing Medical College and Henan Provincial eye hospital. In terms of application, Vistel has established strategic cooperative relations with ophthalmic equipment manufacturers and pharmaceutical companies at home and abroad. Vistel is a national high-tech enterprise, Zhongguancun high-tech enterprise and ZhongGuanCun "golden seed" enterprise. It has published 10 papers and applied for 20 patents at MICCAI and other top meetings.